Protalix Biotherapeutics Inc (PLX) stock is lower by -44.26% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives PLX stock a score of 32 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 0. PLX's rank also includes a short-term technical score of 7. The fundamental score for PLX is 88. In addition to the average rating from Wall Street analysts, PLX stock has a mean target price of 9.75. This means analysts expect the stock to rise 377.94% over the next 12 months.
What's Happening with PLX Stock Today
Protalix Biotherapeutics Inc (PLX) stock is trading at $2.04 as of 1:05 PM on Wednesday, Jun 16, a drop of -$0.10, or -4.46% from the previous closing price of $2.13. The stock has traded between $2.02 and $2.13 so far today. Volume today is high. So far 3,656,138 shares have traded compared to average volume of 2,155,377 shares.
Click Here to get the full Stock Score Report on Protalix Biotherapeutics Inc (PLX) Stock.
